Sphere Fluidics appoints new sales chief for high growth EMEA markets

23 May, 2024
Newsdesk
Cambridge biotech Sphere Fluidics is stepping up its commercial push in the Europe, Middle East and Africa region.
Thumbnail
Curtis Nicholson, Director of Sales for EMEA, Sphere Fluidics.

The company, which provides microfluidics-based solutions for single-cell analysis and isolation, has appointed Curtis Nicholson as Director of Sales for EMEA. His appointment will strengthen the company’s market position in these regions as it progresses ambitious plans for future growth and commercial success.

Nicholson will lead the expansion of the company’s sales and customer support activities to address growing demand for its high-throughput technologies for single-cell analysis and isolation.

Sphere has made a series of senior appointments over the past year, including the appointment of Graeme Daniels as Vice-President of Sales and Marketing, to drive the international sales and marketing strategy and scale operations internationally.

Nicholson brings over two decades of experience, having directed strategic sales initiatives within both SMEs and Multinational Enterprises, including holding positions as UK Business Manager of Assay Solutions at Bio-Techne, Technical Sales Specialist at Becton Dickinson, and Application Specialist at Millipore Corporation.

His extensive tenure in the industry has been focused in areas of cutting-edge innovation, proactively responding to the evolving needs of the life science sector and establishing a strong network. He has consistently guided customers through complex challenges with precision and expertise.

Dr Graeme Daniels, VP of Sales and Marketing for Sphere Fluidics, said: “As we enter the next phase of our commercial development and global expansion, it is a pleasure to welcome Curtis to the team to help drive Sphere Fluidics’ strategy to increase international sales and global expansion.”